These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29077044)

  • 21. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    McGovern JA; Meinert C; de Veer SJ; Hollier BG; Parker TJ; Upton Z
    Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.
    Stefansson K; Brattsand M; Ny A; Glas B; Egelrud T
    Biol Chem; 2006 Jun; 387(6):761-8. PubMed ID: 16800737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Serine Protease Inhibitor-Coated Water-Soluble Gold Nanoparticles as a Novel Targeted Approach for the Treatment of Inflammatory Skin Diseases.
    Limón D; Fábrega MJ; Calpena AC; Badia J; Baldomà L; Pérez-García L
    Bioconjug Chem; 2018 Apr; 29(4):1060-1072. PubMed ID: 29406699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikrein-related peptidase 5 contributes to the remodeling and repair of bronchial epithelium.
    Lenga Ma Bonda W; Lavergne M; Vasseur V; Brisson L; Roger S; Legras A; Guillon A; Guyétant S; Hiemstra PS; Si-Tahar M; Iochmann S; Reverdiau P
    FASEB J; 2021 Oct; 35(10):e21838. PubMed ID: 34582061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury.
    Fischer J; Wu Z; Kantyka T; Sperrhacke M; Dimitrieva O; Koblyakova Y; Ahrens K; Graumann N; Baurecht H; Reiss K; Schröder JM; Proksch E; Meyer-Hoffert U
    J Invest Dermatol; 2014 May; 134(5):1305-1312. PubMed ID: 24352040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
    Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
    J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan Oligosaccharides Improve Rosacea-Like Phenotype through Anti-Inflammatory and Epidermal Barrier-Improving Effects.
    Lee SG; Yoon MS; Kim DH; Shin JU; Lee HJ
    Ann Dermatol; 2020 Jun; 32(3):189-196. PubMed ID: 33911737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes.
    Nin M; Katoh N; Kokura S; Handa O; Yoshikawa T; Kishimoto S
    J Dermatol Sci; 2009 Apr; 54(1):17-24. PubMed ID: 19118981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.
    Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126675. PubMed ID: 31521475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7.
    de Souza AS; Pacheco BDC; Pinheiro S; Muri EMF; Dias LRS; Lima CHS; Garrett R; de Moraes MBM; de Souza BEG; Puzer L
    Bioorg Med Chem Lett; 2019 May; 29(9):1094-1098. PubMed ID: 30833107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis.
    Hatano Y; Adachi Y; Elias PM; Crumrine D; Sakai T; Kurahashi R; Katagiri K; Fujiwara S
    Exp Dermatol; 2013 Jan; 22(1):30-5. PubMed ID: 23173934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25-dihydroxyvitamin D
    Kobashi M; Morizane S; Sugimoto S; Sugihara S; Iwatsuki K
    Br J Dermatol; 2017 Jun; 176(6):1525-1532. PubMed ID: 27797397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional gene silencing of kallikrein 5 and kallikrein 7 using siRNA prevents epithelial cell detachment induced by alkaline shock in an in vitro model of eczema.
    Britland S; Hoyle M
    Biotechnol Prog; 2012; 28(2):485-9. PubMed ID: 22095688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and activity of natural food additive triterpenoids as influenced by protein.
    Peng W; Ding F; Jiang YT; Peng YK
    J Agric Food Chem; 2014 Mar; 62(10):2271-83. PubMed ID: 24548018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway.
    Lee HK; Nam GW; Kim SH; Lee SH
    Exp Dermatol; 2006 Jan; 15(1):66-73. PubMed ID: 16364033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
    Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
    J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.